- Home
- RIGL vs MAMA Comparison
RIGL vs MAMA Comparison
Compare RIGL & MAMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RIGL | MAMA |
|---|---|---|
| Founded | 1996 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 564.7M | 602.1M |
| IPO Year | 2000 | 2011 |
Fundamental Metrics
Financial Performance| Metric | RIGL | MAMA |
|---|---|---|
| Price | $32.83 | $17.43 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | ★ $45.67 | $19.00 |
| AVG Volume (30 Days) | 279.0K | ★ 458.4K |
| Earning Date | 05-05-2026 | 04-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1867.68 | 44.44 |
| EPS | ★ 0.44 | 0.05 |
| Revenue | ★ $294,282,000.00 | $95,420,129.00 |
| Revenue This Year | N/A | $31.09 |
| Revenue Next Year | $12.75 | $16.12 |
| P/E Ratio | ★ $76.05 | $313.60 |
| Revenue Growth | 64.15 | ★ 95.54 |
| 52 Week Low | $18.14 | $7.82 |
| 52 Week High | $52.24 | $17.85 |
Technical Indicators
Market Signals| Indicator | RIGL | MAMA |
|---|---|---|
| Relative Strength Index (RSI) | 61.89 | 70.27 |
| Support Level | $28.14 | $13.06 |
| Resistance Level | $33.09 | $17.85 |
| Average True Range (ATR) | 1.40 | 0.87 |
| MACD | 0.29 | 0.24 |
| Stochastic Oscillator | 73.86 | 96.61 |
Price Performance
Historical ComparisonAbout RIGL Rigel Pharmaceuticals Inc.
Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, REZLIDHIA (olutasidenib), GAVRETO (pralsetinib), R289, and Ocadusertib (Systemic) - Eli Lilly.
About MAMA Mama's Creations Inc.
Mama's Creations Inc manufactures and markets fresh deli-prepared foods distributed through grocery, mass, club, and convenience stores across the United States. Its product portfolio includes refrigerated prepared foods such as meatballs, meatloaf, sausage products, and pasta and rice entrees. The products are principally sold to supermarkets, club chains, mass-market retailers, and food distributors. The brand of the company includes Mama's Creations, Mama's Mancini's, The Olive Branch, Creative Salads, and others.